Union Korea Pharm Co., Ltd. (KOSDAQ:080720)
South Korea flag South Korea · Delayed Price · Currency is KRW
2,725.00
-310.00 (-10.21%)
At close: Oct 11, 2024

Union Korea Pharm Revenue

Union Korea Pharm had revenue of 7.13B KRW in the quarter ending September 30, 2025, a decrease of -54.80%. This brings the company's revenue in the last twelve months to 33.83B, down -47.22% year-over-year. In the year 2024, Union Korea Pharm had annual revenue of 51.28B, down -18.82%.

Revenue (ttm)
33.83B
Revenue Growth
-47.22%
P/S Ratio
0.58
Revenue / Employee
203.80M
Employees
166
Market Cap
19.70B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202451.28B-11.89B-18.82%
Dec 31, 202363.17B1.88B3.06%
Dec 31, 202261.29B12.99B26.89%
Dec 31, 202148.30B-2.08B-4.12%
Dec 31, 202050.38B-885.13M-1.73%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
WooGene B&G 54.77B
Kwangdong Healthbio 38.10B
BIFIDO 18.65B
Daesung Microbiological Labs. 25.86B
Future Medicine 1.00B
ChoA Pharmaceutical Co., LTD. 60.50B
Pharmsville 13.36B
Hurum 95.37B
Revenue Rankings